BOTOX+
Allergan, Inc.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 97041758 |
| Mark Literal Elements | None |
| Mark Drawing Type | 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S) |
| Standard Character Claim | No |
| Current Location | Not Found |
| Basis | No |
| Filed Use | No |
| Current Use | No |
| Intent To Use | No |
| Filed ITU | No |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
Timeline
| 2021-07-26 | Status: Live/Pending |
| 2021-07-26 | Status: New application will be assigned to an examining attorney approximately 6 months after filing date. |
| 2021-09-23 | Application Filed |
| 2021-10-25 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Allergan, Inc. |
| Address | 2525 Dupont Drive Irvine DE 92612 |
| Legal Entity Type | Corporation |
| Legal Entity State | DE |
Documents
 Application | MULTI | 2021-09-23 |
 Drawing | JPEG | 2021-09-23 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 41 |
| U.S. Codes: | 100,101,107 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0441 | Promoting and enhancing healthcare professionals understanding and awareness of botulinum toxin through educational offerings via a website, access to product support, social media, and dissemination of emails in conjunction therewith |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-10-25 | 1 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2021-11-24 | 2 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2021-11-29 | 3 CNRT R:Renewal |
| NON-FINAL ACTION E-MAILED | 2021-11-29 | 4 GNRT F:First Action |
| NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2021-11-29 | 5 GNRN O:Outgoing Correspondence |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-05-13 | 6 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-05-13 | 7 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-05-13 | 8 TEME I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-05-16 | 9 CNSA P: |
| ASSIGNED TO LIE | 2022-05-18 | 10 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2022-05-19 | 11 PREV O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-06-01 | 12 NONP E:E-Mail |
| PUBLISHED FOR OPPOSITION | 2022-06-21 | 13 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-06-21 | 14 NPUB E:E-Mail |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2022-08-16 | 15 NOAM E:E-Mail |
| TEAS EXTENSION RECEIVED | 2023-02-15 | 16 EEXT I:Incoming Correspondence |
| SOU EXTENSION 1 FILED | 2023-02-15 | 17 EXT1 S: |
| SOU EXTENSION 1 GRANTED | 2023-02-15 | 18 EX1G S: |
| NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2023-02-17 | 19 EXRA E:E-Mail |
| ABANDONMENT - NO USE STATEMENT FILED | 2023-09-18 | 20 ABN6 S: |
| ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | 2023-09-18 | 21 MAB6 E:E-Mail |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 